XBiotech Inc.

6.04 USD
-0.04 (-0.66%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

XBiotech Inc. stock is down -29.27% since 30 days ago. The next earnings date is Aug 9, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 9 June’s closed higher than May.

About XBiotech Inc.

XBiotech Inc. discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis.